Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 4/20 | 0.42 |
| ▸ | ESR1 | P03372 | 8/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 7/20 | 0.39 |
| ▸ | AR | P10275 | 2/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15747030 | 0.89 | DAO (0.36) | KIF11ESR1ESR2ARHSD11B1 | |
| SCHEMBL47866 | 0.84 | ESR1 (0.46) | KIF11ESR1ESR2ARTP53 | |
| SCHEMBL29728144 | 0.84 | ESR1 (0.46) | KIF11ESR1ESR2ARTP53 | |
| SCHEMBL19465208 | 0.83 | DAO (0.35) | ESR1ESR2DAO | |
| SCHEMBL13538944 | 0.82 | ESR1 (0.50) | KIF11ESR1ESR2ARTP53 | |
| SCHEMBL10268650 | 0.81 | KIF11 (0.46) | KIF11ESR1ESR2S1PR1DAO | |
| SCHEMBL20826225 | 0.79 | KIF11 (0.45) | KIF11ESR1ESR2ARHSD11B1 | |
| SCHEMBL26939102 | 0.79 | KIF11 (0.45) | KIF11ESR1ESR2ARHSD11B1 | |
| SCHEMBL22000812 | 0.79 | TAAR1 (0.31) | ESR1ESR2DAO | |
| SCHEMBL19494607 | 0.78 | LMNA (0.38) | HSD11B1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9056285-B2 | Gas separation membrane | CENTRAL GLASS COMPANY, LIMITED (JP) | 2015-06-16 | — | — | US | disclosed |
| US-20140144325-A1 | Gas Separation Membrane | CENTRAL GLASS COMPANY, LIMITED (JP) | 2014-05-29 | — | — | US | disclosed |
| US-20140148548-A1 | Fluorine-Containing Polymerizable Monomer And Polymer Compound Using Same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2014-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140148548-A1 | Fluorine-Containing Polymerizable Monomer And Polymer Compound Using Same | AFF4, AFF2, AFF1 | KIF11 410/4885ESR1 1496/4885ESR2 2198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.